Suchergebnisse - "van der Heijde, Désirée"

PubPharm (61)

1

The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis : study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial

enthalten in: Trials | 2023

von Ritchlin, C. | Coates, L. | Mease, P. | +6

2

Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis : results from open-label extension

enthalten in: Rheumatology (Oxford, England) | 2022

von van der Heijde, D. | Dougados, M. | Maksymowych, W. | +6

3

Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis : 2-year (end-of-study) results from the FUTURE 5 study

enthalten in: RMD open | 2021

von Mease, P. | Landewé, R. | Rahman, P. | +9

4

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis : an ancillary study to a randomized controlled trial (ASSERT)

enthalten in: Arthritis research & therapy | 2020

von Webers, C. | Stolwijk, C. | Schiepers, O. | +5

5

Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis : design of a pragmatic open-label, randomised, non-inferiority trial

enthalten in: Trials | 2020

von Michielsens, C. | Boers, N. | den Broeder, N. | +8

6

Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2019

von Deodhar, A. | Gensler, L. | Sieper, J. | +10

CommentIn: Arthritis Rheumatol. 2019 Feb;71(2):179-181. - PMID 30600936

7

Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression : primary results from the randomised, double-blind, phase III FUTURE 5 study

enthalten in: Annals of the rheumatic diseases | 2018

von Mease, P. | van der Heijde, D. | Landewé, R. | +10

CommentIn: Ann Rheum Dis. 2019 Sep;78(9):e97. - PMID 29853450

8

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2016 update

enthalten in: Annals of the rheumatic diseases | 2017

von Smolen, J. | Landewé, R. | Bijlsma, J. | +46

CommentIn: Ann Rheum Dis. 2017 Nov;76(11):e47. - PMID 28347992

9

Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis : results of the randomized, placebo-controlled GO-RAISE study

enthalten in: Arthritis research & therapy | 2016

von Inman, R. | Baraliakos, X. | Hermann, K. | +5

10

Management of psoriatic arthritis in 2016 : a comparison of EULAR and GRAPPA recommendations

enthalten in: Nature reviews. Rheumatology | 2016

von Gossec, L. | Coates, L. | de Wit, M. | +6

1
2
3
4
5
6
7
Nächster »
[7]